Post-Transcriptional Regulation of Polycistronic MicroRNAs in Mammalian Cells

哺乳动物细胞中多顺反子 MicroRNA 的转录后调控

• 批准号: 7568843
• 负责人: Joel R Neilson
• 金额: $ 13.81万
• 依托单位: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-02-12 至 2009-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7568843
• 关键词: Affect; Alleles; Animals; Award; Biochemical; Biochemistry; Biogenesis; Bioinformatics; Biology; Cell Death; Cells; Comprehension; Core Facility; Data; Development; Ectopic Expression; Educational process of instructing; Exposure to; Fellowship; Gene Expression; Gene Expression Regulation; Genes; Genetic; Genomics; Head; Immunologist; Immunology; In Vitro; Individual; Institution; Kinetics; Knowledge; Laboratories; Large Intestine Carcinoma; Lymphoma; MYC gene; Malignant Neoplasms; Mammalian Cell; Mentors; Messenger RNA; MicroRNAs; Modeling; Mus; Mutant Strains Mice; NCI Center for Cancer Research; Oncogenic; Pathway interactions; Phase; Physiological; Play; Post-Transcriptional Regulation; Process; Proteins; RNA; Relative (related person); Research; Research Personnel; Resources; Role; Specificity; Staging; T-Lymphocyte; Thymocyte Development; Thymus Gland; Time; Training; Transcript; Tumor Biology; Tumor Cell Line; Tumor Suppressor Genes; Work; c-myc Genes; cell type; member; mouse model; programs; research study; skills; therapeutic gene; thymocyte; tumor

DESCRIPTION (provided by applicant): Dr. Neilson is a trained developmental immunologist/mouse geneticist who has used the first portion of his postdoctoral fellowship in Phillip A. Sharp's lab at the the MIT Center for Cancer Research to gain a deeper understanding of short RNA biology, as well as to become facile with in vitro experimental approaches. Dr. Neilson's objective is to head an academic laboratory at a top research institution. During the mentored phase of the award period, Dr. Neilson aims to strengthen his exposure to the fields of biochemistry and bioinformatics. Training in the latter field in particular is increasingly important. During the mentored phase of the proposal, Dr. Neilson will generate mice with conditional alleles of the miR-92-1 locus. He will also initiate a biochemical characterization of the oncogenic miR-17-92 cluster as outlined in the proposal. Dr. Sharp's ability to mentor this mode of experimentation is unparalleled. Simultaneously, Dr. Neilson will take academic and non-academic courses to become fluent in programming and bioinformatic approaches, and teach an advanced undergraduate course in short RNAs and immunology. MIT and the Center for Cancer research have outstanding core facilities and academic resources relevant to these purposes. Once the mentored phase has been completed, Dr. Neilson and his trainees will continue the characterization of the mouse mutants proposed herein. Dr. Neilson's newly acquired biochemical and bioinformatic skill sets will be used in parallel with his existing knowledge of mammalian development and immunology to characterize the consequences of miR-92-1 disruption at the phenotypic, biochemical, and genomic levels. The consequences of miR-92-1 disruption in the context of the biochemical experiments performed during the mentored phase will be examined. The discovery of gene regulation by a new class of genes termed miRNAs has fundamentally changed the scientific view of how cells control gene expression. Several of these genes have been implicated in cancer. A detailed understanding how miRNAs work and how they themselves are controlled will allow a fuller comprehension of mammalian biology, at the same time enabling more effective exploitation of the pathway giving rise to these genes for therapeutic purposes (RNAi).

简介（由申请人提供）：Dr. Neilson是一名训练有素的发育免疫学家/小鼠遗传学家，他在麻省理工学院癌症研究中心Phillip a . Sharp实验室的博士后奖学金的第一部分获得了对短RNA生物学的更深入的理解，并熟练掌握了体外实验方法。尼尔森博士的目标是领导一家顶尖研究机构的学术实验室。